PIIIW Capital Expenditures from 2010 to 2024

PIIIW Stock  USD 0.01  0  21.17%   
P3 Health Capital Expenditures yearly trend continues to be fairly stable with very little volatility. Capital Expenditures will likely drop to about 1.3 M in 2024. During the period from 2010 to 2024, P3 Health Capital Expenditures regression line of quarterly data had mean square error of 745.4 B and geometric mean of 0.00. View All Fundamentals
 
Capital Expenditures  
First Reported
2010-12-31
Previous Quarter
1.8 M
Current Value
1.3 M
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91 M, Interest Expense of 15.2 M or Selling General Administrative of 116.2 M, as well as many indicators such as Price To Sales Ratio of 0.0932, Dividend Yield of 0.0 or PTB Ratio of 0.83. PIIIW financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out the analysis of P3 Health Correlation against competitors.

Latest P3 Health's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of P3 Health Partners over the last few years. Capital Expenditures are funds used by P3 Health Partners to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of P3 Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is P3 Health's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Slightly volatile
   Capital Expenditures   
       Timeline  

PIIIW Capital Expenditures Regression Statistics

Arithmetic Mean2,483,620
Geometric Mean0.00
Coefficient Of Variation50.03
Mean Deviation1,049,088
Median3,308,638
Standard Deviation1,242,668
Sample Variance1.5T
Range3.3M
R-Value(0.74)
Mean Square Error745.4B
R-Squared0.55
Significance0
Slope(206,409)
Total Sum of Squares21.6T

PIIIW Capital Expenditures History

20241.3 M
20231.8 M
2022 2233.0
2021null
20202.9 M
20191.5 M

About P3 Health Financial Statements

P3 Health investors use historical fundamental indicators, such as P3 Health's Capital Expenditures, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in P3 Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Expenditures1.8 M1.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.